New tests launched in February - Insights
In February 2022, Mayo Clinic Laboratories announced fourteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Stiff-Person/PERM Evaluation - Insights
Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' stiff-person assay provides comprehensive evaluation for individuals on the spectrum of stiff-person syndrome. In addition to guiding treatment decisions, the assay...
epilepsy_unexplained_refractory_and_or_familial_testing_algorithm.pdf
Unexplained refractory and/or suspect familial epilepsy: All patients should have completed ■ Magnetic resonance imaging (MRI) ■ Electroencephalogram Consider: metabolic or autoimmune testing based on clinical presentation (see...
platelet_antibody_algorithm.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 05/2024 Platelet Antibody Testing Algorithm Autoimmune cause of thrombocytopenia suspected, such as: ■ Idiopathic thrombocytopenia purpura (ITP) ■ Secondary...
laboratory_approach_to_the_diagnosis_of_amyloidosis.pdf
04/2024© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Amyloidosis: Laboratory Approach to Diagnosis Possible patient presentations: ■ Nephrotic-range proteinuria with or without renal insufficiency...
Membranous nephropathy - Insights
Membranous nephropathy (MN) is one of the leading causes of nephrotic syndrome in adults. Our menu of clinically validated assays assists with diagnosis, monitors disease progression, and guides clinical outcomes.
Autoimmune Liver Disease Testing - Mayo Clinic Laboratories
Our panel evaluates smooth muscle antibodies (SMA), antinuclear antibodies (ANA), and antimitochondrial antibodies (AMA) for patients with suspected autoimmune liver disease, specifically type 1 AIH or PBC or with liver disease of unknown...
Unique pediatric evaluation targets relevant autoimmune/CNS antibodies - Insights
Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' pediatric autoimmune/CNS testing can better guide the treatment of autoimmune neurological diseases in children. The tailored evaluation covers only biomarkers...
New tests launched in October - Insights
In October 2021, Mayo Clinic Laboratories announced eleven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
MCL First TrimesterSequential Maternal Screening Patient Information MC1235122
MCL TrimesterSequential Maternal Screening Patient Information Complete print Reset Form Trimester Sequential Maternal Screening Patient Information Patient Information Middle Birth Date